l'iARMACEUTIC,._1- FDA-approved Altren (altrenogest)Solution 0.22% is indicated tosuppress estrus in mares. Altren is theonly oral progestin available in a 150 mL single horse dosing packageFDA APPROVEDquickly andsafely reduces the moodiness andtemperament changes oftenassociated with estrus and keepsyour mare out of heat for all hermajor eventsPROVEN PERFORMANCEcontainsthe same active ingredient anddosing regimen as Regu-MateECONOMICAL PACKAGINGunique, 150 mL individualized treatmentpackage keeps product cost downand assures effective treatmentManagingEstrus to FitYour ScheduleAltren (altrenogest) Solution 0.22% is contraindicated for use in mares with a previous or current history of uterine inflammation. Talk to your veterinarian about proper use and safe handling of Altren. Avoid skin contact and always wear protective gloves when administering. Pregnant women, or women who suspect they are pregnant, should not handle Altren. Refer to the package insert by visiting www.aurorapharmaceutical.com for complete product information. For more information on Altren is a Registered Trademark of Aurora Pharmaceutical, Inc.Altren consult your Regu-Mate is a Registered Trademark of Merck Animal Health veterinarian or equine MANUFACTURED IN THE USA health care professionalad00006408/2019www.aurorapharmaceutical.comAltren Ad.indd 1 8/23/19 10:51 AMAurora_pg.indd 1 9/19/19 3:31 PM""/>
l'iARMACEUTIC,._1- FDA-approved Altren (altrenogest)Solution 0.22% is indicated tosuppress estrus in mares. Altren is theonly oral progestin available in a 150 mL single horse dosing packageFDA APPROVEDquickly andsafely reduces the moodiness andtemperament changes oftenassociated with estrus and keepsyour mare out of heat for all hermajor eventsPROVEN PERFORMANCEcontainsthe same active ingredient anddosing regimen as Regu-MateECONOMICAL PACKAGINGunique, 150 mL individualized treatmentpackage keeps product cost downand assures effective treatmentManagingEstrus to FitYour ScheduleAltren (altrenogest) Solution 0.22% is contraindicated for use in mares with a previous or current history of uterine inflammation. Talk to your veterinarian about proper use and safe handling of Altren. Avoid skin contact and always wear protective gloves when administering. Pregnant women, or women who suspect they are pregnant, should not handle Altren. Refer to the package insert by visiting www.aurorapharmaceutical.com for complete product information. For more information on Altren is a Registered Trademark of Aurora Pharmaceutical, Inc.Altren consult your Regu-Mate is a Registered Trademark of Merck Animal Health veterinarian or equine MANUFACTURED IN THE USA health care professionalad00006408/2019www.aurorapharmaceutical.comAltren Ad.indd 1 8/23/19 10:51 AMAurora_pg.indd 1 9/19/19 3:31 PM"" />
Flipbook
b"~ F>l'iARMACEUTIC,._1- FDA-approved Altren (altrenogest)Solution 0.22% is indicated tosuppress estrus in mares. Altren is theonly oral progestin available in a 150 mL single horse dosing packageFDA APPROVEDquickly andsafely reduces the moodiness andtemperament changes oftenassociated with estrus and keepsyour mare out of heat for all hermajor eventsPROVEN PERFORMANCEcontainsthe same active ingredient anddosing regimen as Regu-MateECONOMICAL PACKAGINGunique, 150 mL individualized treatmentpackage keeps product cost downand assures effective treatmentManagingEstrus to FitYour ScheduleAltren (altrenogest) Solution 0.22% is contraindicated for use in mares with a previous or current history of uterine inflammation. Talk to your veterinarian about proper use and safe handling of Altren. Avoid skin contact and always wear protective gloves when administering. Pregnant women, or women who suspect they are pregnant, should not handle Altren. Refer to the package insert by visiting www.aurorapharmaceutical.com for complete product information. For more information on Altren is a Registered Trademark of Aurora Pharmaceutical, Inc.Altren consult your Regu-Mate is a Registered Trademark of Merck Animal Health veterinarian or equine MANUFACTURED IN THE USA health care professionalad00006408/2019www.aurorapharmaceutical.comAltren Ad.indd 1 8/23/19 10:51 AMAurora_pg.indd 1 9/19/19 3:31 PM"